Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Horowitz

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
American Heart Journal|May 16, 2016
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trialRaffaele De Caterina, Ulrika Andersson, John H Alexander, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 28, 2020
Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trialRaffaele De Caterina, Giuseppe Patti, Johan Westerbergh, et al.
Lancet (London, England)|October 6, 2012
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trialRenato D Lopes, Sana M Al-Khatib, Lars Wallentin, et al.
Circulation Research|October 18, 2024
Shear-Sensing by C-Reactive Protein: Linking Aortic Stenosis and InflammationJohannes Zeller, Julia Loseff-Silver, Khashayar Khoshmanesh, et al.
The New England Journal of Medicine|August 30, 2011
Apixaban versus warfarin in patients with atrial fibrillationChristopher B Granger, John H Alexander, John J V McMurray, et al.
JAMA Cardiology|March 30, 2022
Assessment of Artificial Intelligence in Echocardiography Diagnostics in Differentiating Takotsubo Syndrome From Myocardial InfarctionFabian Laumer, Davide Di Vece, Victoria L Cammann, et al.
Journal of the American College of Cardiology|August 18, 2018
Long-Term Prognosis of Patients With Takotsubo SyndromeJelena R Ghadri, Ken Kato, Victoria L Cammann, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
American Heart Journal|May 16, 2016
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trialRaffaele De Caterina, Ulrika Andersson, John H Alexander, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 28, 2020
Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trialRaffaele De Caterina, Giuseppe Patti, Johan Westerbergh, et al.
Lancet (London, England)|October 6, 2012
Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trialRenato D Lopes, Sana M Al-Khatib, Lars Wallentin, et al.
Circulation Research|October 18, 2024
Shear-Sensing by C-Reactive Protein: Linking Aortic Stenosis and InflammationJohannes Zeller, Julia Loseff-Silver, Khashayar Khoshmanesh, et al.
The New England Journal of Medicine|August 30, 2011
Apixaban versus warfarin in patients with atrial fibrillationChristopher B Granger, John H Alexander, John J V McMurray, et al.
JAMA Cardiology|March 30, 2022
Assessment of Artificial Intelligence in Echocardiography Diagnostics in Differentiating Takotsubo Syndrome From Myocardial InfarctionFabian Laumer, Davide Di Vece, Victoria L Cammann, et al.
Journal of the American College of Cardiology|August 18, 2018
Long-Term Prognosis of Patients With Takotsubo SyndromeJelena R Ghadri, Ken Kato, Victoria L Cammann, et al.
Pageof 4